ferne - PowerPoint PPT Presentation

1 / 59
About This Presentation
Title:

ferne

Description:

Title: ferne Last modified by: FERNEA Created Date: 5/26/2000 6:35:20 PM Document presentation format: On-screen Show Other titles: Times New Roman Arial Msapps Slide ... – PowerPoint PPT presentation

Number of Views:94
Avg rating:3.0/5.0
Slides: 60
Provided by: uicEduco
Learn more at: http://www.uic.edu
Category:
Tags: ferne | maturation

less

Transcript and Presenter's Notes

Title: ferne


1
A Diabetic Male with AMS, Fever, and
Hallucinations
2
Edward P. Sloan, MD, MPHAssociate
ProfessorDepartment of Emergency
MedicineUniversity of Illinois College of
MedicineChicago, IL
3
Attending PhysicianEmergency MedicineUniversity
of Illinois HospitalOur Lady of the
Resurrection HospitalChicago, IL
4
(No Transcript)
5
(No Transcript)
6
Global Objectives
  • Maximize patient outcome
  • Utilize health care resources well
  • Optimize evidence-based medicine
  • Enhance ED practice

7
Sessions Objectives
  • Present case
  • Review key concepts
  • Consider relevant questions
  • Examine treatment options
  • Develop reasonable Rx strategies

8
EMS Presentation
  • 51 year old 0028 CFD EMS call for AMS
  • Per family, high temp, flu-like symptoms
  • Fever and hallucinations
  • Hot, flushed, diaphoretic, O x 1
  • VS 140/P, HR 120, RR 30
  • Glucose 300
  • Hx DM, HTN
  • Recent viral illness

9
ED Presentation
  • August 2002, Illinois, 101 AM
  • ED Presentation non-verbal, moaning
  • Temp 102.2
  • Responds to verbal, moans Help me.

10
ED History
  • Viral Sx, N/V/D for 2 days
  • Taking NSAIDs, refused PMD admit
  • No drugs or EtOH history
  • Hx psoriasis

11
ED Physical Exam
  • Agitated, confused, combative, diaphoretic
  • Pupils 2-3 mm, non-reactive airway OK
  • Neck supple, no thyromegaly
  • Cardiopulmonary tachycardia, tachypnea
  • Abdomen non-tender
  • Neuro CN grossly normal, no motor
  • weakness, tremor, intermittent nystagmus
  • on central gaze
  • Skin old psoriasis, no new rash

12
Clinical Questions
  • What are the differential diagnoses?
  • What are the etiologies?
  • What tests must be performed?
  • What therapies must be provided?
  • What consultations are required?
  • What outcome is likely?

13
ED Management
  • DDx Viral Sx, AMS
  • R/o encephalitis, meningitis, sepsis
  • Need to R/o West Nile Virus (Illinois)
  • 115 Haldol, ativan
  • 125 RSI with etomidate, pavulon, sux
  • 440 Ceftriaxone 2 gr IV
  • 455 Acyclovir 1 gr IV over 1 hour

14
ED Diagnostics
  • WBC 11,900 Hb 16.1
  • Glu 313, Bicarb 25, chem ok
  • 7.33 / 39 / 79 / 22 / 97
  • CXR no clear infiltrate
  • EKG sinus tach
  • UA no UTI
  • CT no lesions
  • LP Unable x 2

15
Consultations
  • Neuro consult LP under fluoro, EEG
  • ID consult
  • R/o septic shock, resp failure
  • R/o staph, given psoriasis
  • R/o pneumococcal pneumonia
  • R/o meningitis
  • R/o toxic or metabolic
  • encephalopathy
  • Add vancomycin, obtain 2-D echo

16
Hospital Course
  • LP by neurosurgery
  • 20 WBC, 20 RBC, glu 137, protein 32
  • ID viral synd, R/o aseptic meningitis
  • Day 3 Possible sub-endocardial AMI
  • Day 3 Seizure, rx with fosphenytoin
  • Rocephin changed to cefipime, levaquin
  • Day 9 More responsive, temp to 102.6
  • Day 10 Maculopapular rash

17
Hospital Course
  • EEG Non-specific diffuse slowing
  • ECHO LV dysfunction
  • Blood cultures negative
  • Repeat CT maxillary sinus fluid
  • PCR negative for herpes simplex virus
  • Tests for systemic vasculitides negative
  • Ab for myeloperoxidase
  • Ab for proteinase-3

18
Hospital Course
  • Legionella Ag in urine negative
  • Mycoplasm antibody titre negatvie
  • Chlamydia pneumoniae IgG, IgA positive
  • HIV Ab negative
  • Day 11 West Nile Arbovirus (CSF)

19
Patient Outcome
  • PM R Consult Comprehensive rehab
  • Pt extubated, improved neurologically
  • Pt able to understand plan
  • Discharge on day 26
  • nursing home/rehab care
  • able to speak, ambulate
  • beginning to meet needs
  • Seen in ED by same EM MD, doing well

20
Fever, AMS Differential Dx
  • Encephalitis
  • Meningitis
  • Meningoencephalitis
  • Encephalomyelitis
  • Sepsis

21
Viral Encephalitis Etiologies
  • Arboviruses mosquitoes, ticks
  • Herpes viruses
  • Herpes simplex
  • Epstein-Barr
  • CMV
  • Varicella zoster
  • Measles virus

22
Encephalitis Pathophysiology
  • Brain inflammation
  • Usually caused by a viral etiology
  • Focal, multi-focal, or diffuse
  • Cerebral edema, hemorrhage, neuronal death

23
Encephalitis Pathophysiology
  • Blood borne CNS infection
  • Diffuse encephalitis
  • Transmitted thru other tissue
  • Focal infection
  • DNA or RNA viruses

24
Arbovirus Encephalitis
  • Mosquitoes or ticks (vectors)
  • Vector-transmitted infection
  • Mosquitoes
  • 10 encephalitis rate if infected
  • 150 to 3000 cases per year
  • Ticks
  • Rocky Mountain spotted fever
  • Non-US Russian encephalitis

25
Herpes Virus Encephalitis
  • Able to lie dormant and reactivate
  • HSV causes 10-20 of all cases
  • 2 per 1,000,000 persons per year
  • Usually HSV-1 from oral herpes
  • Children, both HSV-1 and 2
  • Only treatable cause of encephalitis

26
Varicella Encephalitis
  • Bad if related to chicken pox
  • Adults and children
  • In zoster, less severe unless immunocompromised
  • Both types are rare

27
Epstein-Barr Encephalitis
  • Related to mononucleosis
  • Fatigue, sore throat, HA, fever
  • 1 encephalitis rate
  • Usually mild

28
CMV Encephalitis
  • 5-10 complication rate
  • In HIV patients, 50 complicated
  • Significant mortality

29
Other Encephalitis Causes
  • Rabies
  • Severe, fatal
  • 16 cases between 1980-91 8 US
  • Measles, influenza
  • Adenoviruses
  • 30 mortality rate if encephalitis
  • Symptoms of meningitis, coma
  • Parasites raccoons, toxoplasmosis

30
What is ADEM?
  • Acute disseminated encephalomyelitis
  • Non-infectious encephalitis
  • 2-3 weeks after a viral illness
  • 1/3 of encephalitis cases
  • Varicella, URIs are common causes
  • Autoimmune reaction, white matter
  • Myelin sheath damage, as in MS

31
Arbovirus Encephalitis
  • Eastern equine
  • Western Equine
  • St Louis
  • California
  • Japanese B
  • West Nile

32
Arbovirus Encephalitis Sx
  • St Louis West Nile common in US
  • Less than 1 cause CNS symptoms
  • Sx 2-14 days post-exposure
  • Fever, HA, N/V, lethargy
  • West Nile Virus
  • Maculopapular rash, morbilliform rash
  • Loss of muscle tone and weakness

33
Arbovirus Motor Sx
  • Motor disorders common
  • Severe general weakness
  • Ataxia, voluntary motor problems
  • Tremor, partial paralysis
  • Dysphagia, Brocas aphasia
  • Hearing and visual symptoms

34
Encephalitis Sx
  • Sudden onset
  • Meningismus
  • Stupor, coma
  • Seizures, partial paralysis
  • Confusion, psychosis
  • Speech, memory symptoms

35
Encephalitis Diagnosis
  • Find treatable etiologies
  • CT no changes early
  • MRI early HSV changes detectable
  • EEG temporal lobe HSV changes
  • LP elevated WBCs and protein
  • Labs
  • Leukocytosis, LFTs, coags, chem, tox
  • Viral cultures

36
Encephalitis Serum Ab Tests
  • Virus only at 2-4 days (too early)
  • Serum Ab titres
  • Low early levels
  • 4-fold increase in convalescent tires
  • Obtained 3-5 weeks after sx onset
  • PCR will replicate virus DNA
  • Quick results (hours)
  • Sensitivity equal to viral culture

37
Ruling Out Viral Meningitis
  • Self limited
  • Headache, photosensitivity
  • Stiff neck
  • Fever, N/V, fatigue also common
  • Confusion, psychosis not seen
  • Exclude mycoplasma, legionnella

38
Treating Viral Encephalitis
  • Antibiotics for presumed meningitis
  • Acyclovir for presumed HSV Dx
  • Steroids?
  • Supportive therapies
  • Seizure Rx
  • Sedation
  • Airway control
  • Pain and fever meds

39
Viral Encephalitis Anti-virals
  • Acyclovir for presumed HSV, HZ
  • Foscarnet (Foscavir)
  • When resistant to Acyclovir
  • If adverse reaction to Acyclovir
  • Foscarnet or gancyclovir in CMV
  • Ribavirin (Virazole)

40
Encephalitis Pt Outcome
  • 25 relapse rate in HSV disease
  • ? Due to relapse or new viral illness
  • Poorer outcome with
  • Age lt 1, gt 55
  • Immunocompromise
  • Pre-existing neurological problem
  • Specific virus virulence
  • Coma does not bad outcome

41
Encephalitis Pt Outcome
  • Outcome related to mental status at the time
    anti-viral Rx initiated
  • Early use is warranted
  • Long-term sequelae can occur
  • Motor, speech, cognitive
  • Emotional, personality changes
  • Sensory problems (vision, hearing)

42
Encephalitis Vaccines
  • Measles vaccine
  • Varicella vaccine
  • Rabies vaccine, immunoglobulin
  • Japanese encephalitis vaccine
  • Experimental West Nile Virus vaccine

43
West Nile Virus Encephalitis
  • Mosquito-borne, expanding area
  • 1/5 mild febrile illness
  • 1/150 meningitis, encephalitis
  • Advanced age is greatest risk factor
  • Clues as to likely WNV infection
  • Infected birds or cases identified
  • Late summer
  • Profound muscle weakness

44
West Nile Virus Encephalitis
  • IgM Ab testing via Elisa useful
  • Test of serum or CSF
  • False positives can occur
  • Other flaviviral infections (dengue)
  • Prior vaccination (yellow fever)
  • Rapid reporting is essential

45
West Nile Ecology
46
West Nile Ecology
47
U.S. counties reporting any WNV-infected birds in
1999 (N 28 counties)
48
U.S. counties reporting any WNV-infected birds in
2000 (N 136 counties)
49
U.S. counties reporting any WNV-infected birds in
2001 (N 328 counties)
50
U.S. Counties Reporting WNV-Positive Dead Birds,
2002
15,745 birds 1,888 counties 42 states D.C.
Edward P. Sloan, MD, MPH
51
West Nile Virus
52
WNV Encephalitis Diagnosis
  • Leukocytosis, lymphocytopenia
  • Hyponatremia
  • CSF pleocytosis, lymphocytes
  • Elevated CSF protein
  • Normal CT
  • MR enhanced leptomeninges or periventricular
    areas

53
Encephalitis MR Findings
  • Inflamed portion of the temporal lobe, involving
    the uncus and adjacent parahippocampal gyrus, in
    brightest white on MR.

54
WNV Antibody Diagnosis
  • ELISA detection of WNV IgM
  • 95 CSF WNV IgM rate
  • IgM does note cross BBB
  • CSF IgM suggests CNS infection
  • 90 remain positive if tested within 8 days on
    symptom onset

55
WNV Antibody Diagnosis
  • Asymptomatic pts common
  • In endemic area, IgM could be high
  • Acute, convalescent titres
  • Viral culture low yield
  • Real-time PCR
  • 55 CSF positive, 10 serum

56
WNV Encephalitis Pt Outcome
  • Overall, 4-14 mortality
  • Age gt 70, 15-29 mortality
  • DM, immunosuppression also predict worse outcome

57
WNV Encephalitis Prevention
  • Reducing the of vector mosquitoes
  • Draining standing water sites
  • Methoprene spraying (no maturation)
  • Adulticides (organophos, pyrethroids)
  • Prevent mosquito bites
  • 50 DEET, 10 DEET in children
  • Permethrin to clothing, fabrics
  • Citronella (less effective)

58
Key Learning Points
  • AMS, fever, weakness encephalitis
  • Know clues for West Nile virus
  • Early use of ceftriaxone, acyclovir
  • Supportive care essential
  • Consultation for best diagnostics
  • Reportable public health disease
  • Prevention is best approach

59
Questions?
FERNE www.ferne.org edsloan_at_uic.edu 312 413
7490
Write a Comment
User Comments (0)
About PowerShow.com